Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AS Orthana
- Development stage
- Unknown
- Lead developer
- A/S Orthana Kemisk Fabrik
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Topical
01
Overview
AS Orthana (also known as Saliva Orthana) is a mucin-based artificial saliva substitute used for the palliative management of xerostomia (dry mouth). Formulated as an oral spray or solution, its primary active ingredient is porcine gastric mucin, which mimics the rheological and lubricating properties of natural human saliva. It is indicated for patients suffering from dry mouth caused by radiotherapy, Sjögren's syndrome, or medication side effects. By coating the oral mucosa, it provides long-lasting moisture and lubrication, improving speech, swallowing, and overall oral comfort.
- Brand names
- Saliva OrthanaAS Saliva Orthana
- Other names
- AS Saliva OrthanaSaliva Orthana
Beyond the preview
Go deeper on AS Orthana.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AS Orthana.